Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18266224rdf:typepubmed:Citationlld:pubmed
pubmed-article:18266224lifeskim:mentionsumls-concept:C1261473lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C1516477lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0037303lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0035412lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0441772lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C0442711lld:lifeskim
pubmed-article:18266224lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18266224pubmed:issue1lld:pubmed
pubmed-article:18266224pubmed:dateCreated2008-5-13lld:pubmed
pubmed-article:18266224pubmed:abstractTextDetermine outcome of patients with cranial parameningeal sarcoma and concurrent metastases treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV.lld:pubmed
pubmed-article:18266224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18266224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18266224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18266224pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18266224pubmed:languageenglld:pubmed
pubmed-article:18266224pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18266224pubmed:citationSubsetIMlld:pubmed
pubmed-article:18266224pubmed:statusMEDLINElld:pubmed
pubmed-article:18266224pubmed:monthJullld:pubmed
pubmed-article:18266224pubmed:issn1545-5017lld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:MeyerWilliamWlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:DonaldsonSara...lld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:BrenemanJohnJlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:AndersonJames...lld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:MichalskiJeff...lld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:RaneyBeverlyBlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:UllrichFredFlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:QualmanStephe...lld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:WharamMoodyMlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:HuhWinstonWlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:MaurerHaroldHlld:pubmed
pubmed-article:18266224pubmed:authorpubmed-author:Soft-Tissue...lld:pubmed
pubmed-article:18266224pubmed:copyrightInfo(c) 2008 Wiley-Liss, Inc.lld:pubmed
pubmed-article:18266224pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18266224pubmed:volume51lld:pubmed
pubmed-article:18266224pubmed:ownerNLMlld:pubmed
pubmed-article:18266224pubmed:authorsCompleteYlld:pubmed
pubmed-article:18266224pubmed:pagination17-22lld:pubmed
pubmed-article:18266224pubmed:dateRevised2009-1-12lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:meshHeadingpubmed-meshheading:18266224...lld:pubmed
pubmed-article:18266224pubmed:year2008lld:pubmed
pubmed-article:18266224pubmed:articleTitleResults in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.lld:pubmed
pubmed-article:18266224pubmed:affiliationChildren's Cancer Hospital, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. rbraney@austin.rr.comlld:pubmed
pubmed-article:18266224pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18266224pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed